Campbell Soup's Q3 sales rise, but snacks division struggles amid economic uncertainty and higher costs.
Bristol Myers and BioNTech form $11.1B partnership to co-develop next-generation cancer drug BNT327, aiming to accelerate trials and expand indications.
Escalating US-China trade tensions drive global bond selloff and Treasury yield surge amid economic uncertainty.
Campbell Soup's Q3 sales rise, but snacks division struggles amid economic uncertainty and higher costs.
Bristol Myers and BioNTech form $11.1B partnership to co-develop next-generation cancer drug BNT327, aiming to accelerate trials and expand indications.
Escalating US-China trade tensions drive global bond selloff and Treasury yield surge amid economic uncertainty.